As one of the isoprenoids and widely derived from many fruits and vegetables, β-ionone (BI) has a potent inhibitory proliferation of cancer cells in vitro and in vivo. However, its exact mechanism is still uncompleted understood and needs to be further verified. Cyclooxygenase-2 (COX-2), as a potential target of cancer chemoprevention, has been played pivotal roles in proliferation of tumor cells and carcinogenesis. Thus, the objective of present study was to determine that BI inhibited the activity of COX-2 in breast cancer and related to cancer cell models. Cell proliferation, DNA synthesis, the distribution of cell cycle, apoptosis induction and the expression of P38-MAPK protein were determined in MCF-7 cells by methylene blue, 3H-thymidine (TdR) incorporation, flow cytometry, TUNEL and Western blotting assays. Quinone reductase (QR) activity was determined in murine hepatoma Hepa1c1c7 cells by enzyme-linked immunosorbent assay (ELISA). The expression of COX-2 in a phorbol-12-myristate-13-acetate (PMA)-induced cell model and mammary tumor tissues was examined by Western blotting and immunohistochemistry. The results showed that BI significantly inhibited cell proliferation and DNA synthesis, arrested the distribution of cell cycle at the S phase or decreased proteins related to cell cycle such as cyclin D1 and CDK4, induced apoptosis and increased the expression of p-P38 in MCF-7 cells. BI at low doses (< 50 μmol/L) significantly increased QR activity, decreased the expression of COX-2 protein and prostaglandin E2 (PEG2) release in cell models. In addition, BI also significantly decreased the expression of COX-2 protein in rat mammary tumor tissues. Therefore, our findings indicate that BI possesses inhibitory proliferation of breast cancer cells through down-regulation of COX-2 activity.
β-Ionone Inhibition MCF-7 cells COX-2 activity
This is a preview of subscription content, log in to check access.
This research was supported by Harbin Science and Technology Innovation Talent Research Special Fund (No. 2017RALXJ005), National Natural Science Fund (No. 30200229) and Health and Family Planning Commission Research Fund of Heilongjiang (2003-125), People’s Republic of China.
Duncan RE, Lau D, El-Sohemy A, Archer MC (2004) Geraniol and beta-ionone inhibit proliferation, cell cycle progression, and cyclin-dependent kinase 2 activity in MCF-7 breast cancer cells independent of effects on HMG-CoA reductase activity. Biochem Pharmacol 68(9):1739–1747CrossRefGoogle Scholar
Ghosh N, Chaki R, Mandal V, Mandal SC (2010) COX-2 as a target for cancer chemotherapy. Pharmacol Rep 62(2):233–244CrossRefGoogle Scholar
Harris RE, Beebe-Donk J, Doss H, Burr Doss D (2005) Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: a critical review of non-selective COX-2 blockade (review). Oncol Rep 13(4):559–583Google Scholar
Harris RE, Beebe-Donk J, Alshafie GA (2007) Cancer chemoprevention by cyclooxygenase 2 (COX-2) blockade: results of case control studies. Subcell Biochem 42:193–212CrossRefGoogle Scholar
He L, Mo H, Hadisusilo S, Qureshi AA, Elson CE (1997) Isoprenoids suppress the growth of murine B16 melanomas in vitro and in vivo. J Nutr 127(5):668–674CrossRefGoogle Scholar
Janakiram NB, Cooma I, Mohammed A, Steele VE, Rao CV (2008) Beta-ionone inhibits colonic aberrant crypt foci formation in rats, suppresses cell growth, and induces retinoid X receptor-alpha in human colon cancer cells. Mol Cancer Ther 7(1):181–190CrossRefGoogle Scholar
Kim SO, Chun KS, Kundu JK, Surh YJ (2004) Inhibitory effects of -gingerol on PMA-induced COX-2 expression and activation of NF-kappaB and p38 MAPK in mouse skin. BioFactors 21(1–4):27–31CrossRefGoogle Scholar
Liu JR, Chen BQ, Yang BF et al (2004a) Apoptosis of human gastric adenocarcinoma cells induced by beta-ionone. World J Gastroenterol 10(3):348–351CrossRefGoogle Scholar
Liu JR, Yang BF, Chen BQ, Yang YM, Dong HW, Song YQ (2004b) Inhibition of beta-ionone on SGC-7901 cell proliferation and upregulation of metalloproteinases-1 and -2 expression. World J Gastroenterol 10(2):167–171CrossRefGoogle Scholar
Liu JR, Yang YM, Dong HW, Sun XR (2005) Effect of beta-ionone in human mammary cancer cells (Er-) by MAPK pathway. Wei sheng yan jiu J Hygiene Res 34(6):706–709Google Scholar
Liu JR, Sun XR, Dong HW et al (2008) Beta-ionone suppresses mammary carcinogenesis, proliferative activity and induces apoptosis in the mammary gland of the Sprague-Dawley rat. Int J Cancer 122(12):2689–2698CrossRefGoogle Scholar
Liu JR, Dong HW, Chen BQ, Zhao P, Liu RH (2009a) Fresh apples suppress mammary carcinogenesis and proliferative activity and induce apoptosis in mammary tumors of the Sprague-Dawley rat. J Agric Food Chem 57(1):297–304CrossRefGoogle Scholar
Liu M, Lin L-Q, Song B-B et al (2009b) Cranberry phytochemical extract inhibits SGC-7901 cell growth and human tumor xenografts in Balb/c nu/nu mice. J Agric Food Chem 57(2):762–768CrossRefGoogle Scholar
Liu JR, Dong HW, Sun XR et al (2010) Effects of beta-ionone on mammary carcinogenesis and antioxidant status in rats treated with DMBA. Nutr Cancer 62(1):58–65CrossRefGoogle Scholar
Ohuchi K, Watanabe M, Yoshizawa K et al (1985) Stimulation of prostaglandin E2 production by 12-O-tetradecanoylphorbol 13-acetate (TPA)-type and non-TPA-type tumor promoters in macrophages and its inhibition by cycloheximide. Biochem Biophys Acta 834(1):42–47CrossRefGoogle Scholar
Vieira A, Heidor R, Cardozo MT et al (2011) Efficacy of geraniol but not of beta-ionone or their combination for the chemoprevention of rat colon carcinogenesis. Braz J Med Biol Res 44(6):538–545CrossRefGoogle Scholar
Wang R-F, Zhang L-H, Shan L-H et al (2013) Effects of the fibroblast activation protein on the invasion and migration of gastric cancer. Exp Mol Pathol 95(3):350–356CrossRefGoogle Scholar
Zhang W, Liu HT (2002) MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Res 12(1):9–18CrossRefGoogle Scholar
Zhang YH, Ma K, Liu JR et al (2018) Gamma-tocotrienol inhibits the invasion and migration of human gastric cancer cells through downregulation of cyclooxygenase-2 expression. Oncol Rep 40(2):999–1007. https://doi.org/10.3892/or.2018.6497Google Scholar